Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for HYDROXYCHLOROQUINE SULFATE
- Effectiveness and Safety of Quinine Sulfate as add-on Therapy for COVID-19 in Hospitalized Adults in Indonesia ( DEAL-COVID19 )
- Hydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung Cancer
- Clinical Trial For Early SARS-CoV-2 (COVID-19) Treatment
- Neoadjuvant mFOLFIRINOX With Perioperative Oral Hydroxychloroquine in Resectable Pancreatic Adenocarcinoma
- Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
- A Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Spontaneous Abortion With Antiphospholipid Syndrome
- A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19
- Testing Dabrafenib and Trametinib With or Without Hydroxychloroquine in Stage IIIC or IV BRAF V600E/K Melanoma
- Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression
- Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult Volunteers
- Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection
- Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19
- Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection
- Favipiravir vs Hydroxychloroquine vs Control in COVID -19
- LY3214996 +/- HCQ in Pancreatic Cancer
- Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19
- Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19
- Asymptomatic COVID-19 Trial
- Novel Agents for Treatment of High-risk COVID-19 Positive Patients
- Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk
- Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)
- Treatment for COVID-19 in High-Risk Adult Outpatients
- Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19
- Military COVID-19 Hydroxychloroquine Pre-exposure and Post-exposure Prophylaxis Study
- Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management
- Hydroxychloroquine for COVID-19
- Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection
- Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals
- Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT
- Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19
- Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Hospitalized Patients With Moderate to Severe COVID-19
- Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)
- COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19
- Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients
- Norwegian Coronavirus Disease 2019 Study
- Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19)
- Hydroxychloroquin (HCQ) in chILD of Genetic Defect
- Effect of Hydroxychloroquine on Atrial Fibrillation Recurrence
- A Study of ABC294640 (Yeliva ®) Alone and in Combination With Hydroxychloroquine Sulfate in Treatment of Patients With Advanced Cholangiocarcinoma
- A Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy
- Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy
- Hydroxychloroquin (HCQ) in Pediatric Interstitial Lung Disease (ILD)
- Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy: a Self- Controlled Study
- Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion
- To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets
Clinical trials list
click for details